2-[3-carboxy-3-(methylammonio)propyl]-L-histidine

Metabolite details

Identifier

YBMOTEQVMANKGX-JAMMHHFISA-O

InChI Key

YBMOTEQVMANKGX-JAMMHHFISA-O

IUPAC name

1-carboxy-3-(L-histidin-2-yl)-N-methylpropan-1-aminium

Preferred name

2-[3-carboxy-3-(methylammonio)propyl]-L-histidine

INN name

—

Synonym

2-[3-Carboxy-3-(methylammonio)propyl]-L-histidine

ChEBI

CHEBI:16475

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Metabolic Dynamics of In Vitro CD8+ T Cell Activation.
• Multi-Omics Analysis Reveals Disturbance of Nanosecond Pulsed Electric Field in the Serum Metabolic Spectrum and Gut Microbiota
• Diallyl disulfide (DADS) ameliorates intestinal Candida albicans infection by modulating the gut microbiota and metabolites and providing intestinal protection in mice
• Metabolism Disorder Promotes Isoproterenol-induced Myocardial Injury in Mice with High Temperature and High Humidity and High-Fat Diet
• Interaction between Cervical Microbiota and Host Gene Regulation in Caesarean Section Scar Diverticulum
• Mechanism of interventional effect and targets of Zhuyu Pill in regulating and suppressing colitis and cholestasis

Observed in differential profiles

• G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h
• Control_vs_nsPEF_7_day
• G1_PBS_vs_G2_DSS
• Control_vs_Isoproterenol
• Control_vs_CSD
• Control_vs_ZYP_High_Dose